カテゴリ： 世界, 医療/バイオ, Market Monitor Global

精密がん医療のグローバル市場展望 2023年-2029年：がん免疫療法、標的療法

■ 英語タイトル：Precision Cancer Medicine Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14526）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14526
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：117
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[精密がん医療のグローバル市場展望 2023年-2029年：がん免疫療法、標的療法]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の精密がん医療市場規模と予測を収録しています。・世界の精密がん医療市場：売上、2018年-2023年、2024年-2029年
・世界の精密がん医療市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の精密がん医療市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「がん免疫療法」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

精密がん医療のグローバル主要企業は、AbbVie、 Johnson＆Johnson、 Novartis、 Gilead Sciences、 Roche、 Bristol-Myers Squibb、 Amgen、 AstraZeneca、 Merck＆Co、 Takeda、 Merck KGaA、 Seagen、 Eli Lilly、 Ono Pharmaceutical、 Pfizer、 GSK、 Exelixis、 Regeneron、 Innovent、 Hengrui Medicineなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、精密がん医療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の精密がん医療市場：タイプ別、2018年-2023年、2024年-2029年
世界の精密がん医療市場：タイプ別市場シェア、2022年
・がん免疫療法、標的療法

世界の精密がん医療市場：用途別、2018年-2023年、2024年-2029年
世界の精密がん医療市場：用途別市場シェア、2022年
・肺がん、乳がん、前立腺がん、血液がん、その他

世界の精密がん医療市場：地域・国別、2018年-2023年、2024年-2029年
世界の精密がん医療市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における精密がん医療のグローバル売上、2018年-2023年
・主要企業における精密がん医療のグローバル売上シェア、2022年
・主要企業における精密がん医療のグローバル販売量、2018年-2023年
・主要企業における精密がん医療のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
AbbVie、 Johnson＆Johnson、 Novartis、 Gilead Sciences、 Roche、 Bristol-Myers Squibb、 Amgen、 AstraZeneca、 Merck＆Co、 Takeda、 Merck KGaA、 Seagen、 Eli Lilly、 Ono Pharmaceutical、 Pfizer、 GSK、 Exelixis、 Regeneron、 Innovent、 Hengrui Medicine

*************************************************************

・調査・分析レポートの概要
精密がん医療市場の定義
市場セグメント
世界の精密がん医療市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の精密がん医療市場規模
世界の精密がん医療市場規模：2022年 VS 2029年
世界の精密がん医療市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの精密がん医療の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の精密がん医療製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：がん免疫療法、標的療法
精密がん医療のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：肺がん、乳がん、前立腺がん、血液がん、その他
精密がん医療の用途別グローバル売上・予測

・地域別市場分析
地域別精密がん医療市場規模 2022年と2029年
地域別精密がん医療売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
AbbVie、 Johnson＆Johnson、 Novartis、 Gilead Sciences、 Roche、 Bristol-Myers Squibb、 Amgen、 AstraZeneca、 Merck＆Co、 Takeda、 Merck KGaA、 Seagen、 Eli Lilly、 Ono Pharmaceutical、 Pfizer、 GSK、 Exelixis、 Regeneron、 Innovent、 Hengrui Medicine
...

This research report provides a comprehensive analysis of the Precision Cancer Medicine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Precision Cancer Medicine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Precision Cancer Medicine, challenges faced by the industry, and potential opportunities for market players.
The global Precision Cancer Medicine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Precision Cancer Medicine market presents opportunities for various stakeholders, including Lung Cancer, Breast Cancer. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Precision Cancer Medicine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Precision Cancer Medicine market was valued at US$ 152500 million in 2022 and is projected to reach US$ 342520 million by 2029, at a CAGR of 13.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Precision cancer medicine, also known as personalized or targeted cancer therapy, is driven by the growing understanding of cancer’s molecular and genetic complexity. Advances in genomics and biomarker identification have enabled the development of therapies tailored to an individual’s specific cancer characteristics. This approach offers the potential for more effective treatments with fewer side effects compared to traditional chemotherapy. The market benefits from increasing research in oncology, the rise of precision diagnostics, and the growing availability of targeted therapies. However, challenges include the high cost of genetic testing and targeted treatments, as well as the need for comprehensive molecular profiling. Additionally, regulatory approvals and insurance coverage for these therapies can be complex. To maximize the potential of precision cancer medicine, stakeholders must address these challenges, improve accessibility, and continue research into novel biomarkers and therapies to provide tailored cancer care for patients.
Key Features:
The research report on the Precision Cancer Medicine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Precision Cancer Medicine market.
Market Overview: The report provides a comprehensive overview of the Precision Cancer Medicine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Cancer Immunotherapy, Targeted Therapy), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Precision Cancer Medicine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Precision Cancer Medicine market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Precision Cancer Medicine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Precision Cancer Medicine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Precision Cancer Medicine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Precision Cancer Medicine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Precision Cancer Medicine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Precision Cancer Medicine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Precision Cancer Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Cancer Immunotherapy
Targeted Therapy
Market segment by Application
Lung Cancer
Breast Cancer
Prostate Cancer
Blood-related Cancer
Other
Global Precision Cancer Medicine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East＆Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East＆Africa
Major players covered
AbbVie
Johnson＆Johnson
Novartis
Gilead Sciences
Roche
Bristol-Myers Squibb
Amgen
AstraZeneca
Merck＆Co
Takeda
Merck KGaA
Seagen
Eli Lilly
Ono Pharmaceutical
Pfizer
GSK
Exelixis
Regeneron
Innovent
Hengrui Medicine
Outline of Major Chapters:
Chapter 1: Introduces the definition of Precision Cancer Medicine, market overview.
Chapter 2: Global Precision Cancer Medicine market size in revenue.
Chapter 3: Detailed analysis of Precision Cancer Medicine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Precision Cancer Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research＆Analysis Reports
1.1 Precision Cancer Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Precision Cancer Medicine Market Overview
1.4 Features＆Benefits of This Report
1.5 Methodology＆Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions＆Caveats
2 Global Precision Cancer Medicine Overall Market Size
2.1 Global Precision Cancer Medicine Market Size: 2022 VS 2029
2.2 Global Precision Cancer Medicine Market Size, Prospects＆Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities＆Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Precision Cancer Medicine Players in Global Market
3.2 Top Global Precision Cancer Medicine Companies Ranked by Revenue
3.3 Global Precision Cancer Medicine Revenue by Companies
3.4 Top 3 and Top 5 Precision Cancer Medicine Companies in Global Market, by Revenue in 2022
3.5 Global Companies Precision Cancer Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Precision Cancer Medicine Players in Global Market
3.6.1 List of Global Tier 1 Precision Cancer Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Precision Cancer Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Precision Cancer Medicine Market Size Markets, 2022＆2029
4.1.2 Cancer Immunotherapy
4.1.3 Targeted Therapy
4.2 By Type – Global Precision Cancer Medicine Revenue＆Forecasts
4.2.1 By Type – Global Precision Cancer Medicine Revenue, 2018-2023
4.2.2 By Type – Global Precision Cancer Medicine Revenue, 2024-2029
4.2.3 By Type – Global Precision Cancer Medicine Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Precision Cancer Medicine Market Size, 2022＆2029
5.1.2 Lung Cancer
5.1.3 Breast Cancer
5.1.4 Prostate Cancer
5.1.5 Blood-related Cancer
5.1.6 Other
5.2 By Application – Global Precision Cancer Medicine Revenue＆Forecasts
5.2.1 By Application – Global Precision Cancer Medicine Revenue, 2018-2023
5.2.2 By Application – Global Precision Cancer Medicine Revenue, 2024-2029
5.2.3 By Application – Global Precision Cancer Medicine Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Precision Cancer Medicine Market Size, 2022＆2029
6.2 By Region – Global Precision Cancer Medicine Revenue＆Forecasts
6.2.1 By Region – Global Precision Cancer Medicine Revenue, 2018-2023
6.2.2 By Region – Global Precision Cancer Medicine Revenue, 2024-2029
6.2.3 By Region – Global Precision Cancer Medicine Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Precision Cancer Medicine Revenue, 2018-2029
6.3.2 US Precision Cancer Medicine Market Size, 2018-2029
6.3.3 Canada Precision Cancer Medicine Market Size, 2018-2029
6.3.4 Mexico Precision Cancer Medicine Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Precision Cancer Medicine Revenue, 2018-2029
6.4.2 Germany Precision Cancer Medicine Market Size, 2018-2029
6.4.3 France Precision Cancer Medicine Market Size, 2018-2029
6.4.4 U.K. Precision Cancer Medicine Market Size, 2018-2029
6.4.5 Italy Precision Cancer Medicine Market Size, 2018-2029
6.4.6 Russia Precision Cancer Medicine Market Size, 2018-2029
6.4.7 Nordic Countries Precision Cancer Medicine Market Size, 2018-2029
6.4.8 Benelux Precision Cancer Medicine Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Precision Cancer Medicine Revenue, 2018-2029
6.5.2 China Precision Cancer Medicine Market Size, 2018-2029
6.5.3 Japan Precision Cancer Medicine Market Size, 2018-2029
6.5.4 South Korea Precision Cancer Medicine Market Size, 2018-2029
6.5.5 Southeast Asia Precision Cancer Medicine Market Size, 2018-2029
6.5.6 India Precision Cancer Medicine Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Precision Cancer Medicine Revenue, 2018-2029
6.6.2 Brazil Precision Cancer Medicine Market Size, 2018-2029
6.6.3 Argentina Precision Cancer Medicine Market Size, 2018-2029
6.7 Middle East＆Africa
6.7.1 By Country – Middle East＆Africa Precision Cancer Medicine Revenue, 2018-2029
6.7.2 Turkey Precision Cancer Medicine Market Size, 2018-2029
6.7.3 Israel Precision Cancer Medicine Market Size, 2018-2029
6.7.4 Saudi Arabia Precision Cancer Medicine Market Size, 2018-2029
6.7.5 UAE Precision Cancer Medicine Market Size, 2018-2029
7 Precision Cancer Medicine Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Precision Cancer Medicine Major Product Offerings
7.1.4 AbbVie Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.1.5 AbbVie Key News＆Latest Developments
7.2 Johnson＆Johnson
7.2.1 Johnson＆Johnson Company Summary
7.2.2 Johnson＆Johnson Business Overview
7.2.3 Johnson＆Johnson Precision Cancer Medicine Major Product Offerings
7.2.4 Johnson＆Johnson Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.2.5 Johnson＆Johnson Key News＆Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Precision Cancer Medicine Major Product Offerings
7.3.4 Novartis Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News＆Latest Developments
7.4 Gilead Sciences
7.4.1 Gilead Sciences Company Summary
7.4.2 Gilead Sciences Business Overview
7.4.3 Gilead Sciences Precision Cancer Medicine Major Product Offerings
7.4.4 Gilead Sciences Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.4.5 Gilead Sciences Key News＆Latest Developments
7.5 Roche
7.5.1 Roche Company Summary
7.5.2 Roche Business Overview
7.5.3 Roche Precision Cancer Medicine Major Product Offerings
7.5.4 Roche Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.5.5 Roche Key News＆Latest Developments
7.6 Bristol-Myers Squibb
7.6.1 Bristol-Myers Squibb Company Summary
7.6.2 Bristol-Myers Squibb Business Overview
7.6.3 Bristol-Myers Squibb Precision Cancer Medicine Major Product Offerings
7.6.4 Bristol-Myers Squibb Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.6.5 Bristol-Myers Squibb Key News＆Latest Developments
7.7 Amgen
7.7.1 Amgen Company Summary
7.7.2 Amgen Business Overview
7.7.3 Amgen Precision Cancer Medicine Major Product Offerings
7.7.4 Amgen Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.7.5 Amgen Key News＆Latest Developments
7.8 AstraZeneca
7.8.1 AstraZeneca Company Summary
7.8.2 AstraZeneca Business Overview
7.8.3 AstraZeneca Precision Cancer Medicine Major Product Offerings
7.8.4 AstraZeneca Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.8.5 AstraZeneca Key News＆Latest Developments
7.9 Merck＆Co
7.9.1 Merck＆Co Company Summary
7.9.2 Merck＆Co Business Overview
7.9.3 Merck＆Co Precision Cancer Medicine Major Product Offerings
7.9.4 Merck＆Co Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.9.5 Merck＆Co Key News＆Latest Developments
7.10 Takeda
7.10.1 Takeda Company Summary
7.10.2 Takeda Business Overview
7.10.3 Takeda Precision Cancer Medicine Major Product Offerings
7.10.4 Takeda Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.10.5 Takeda Key News＆Latest Developments
7.11 Merck KGaA
7.11.1 Merck KGaA Company Summary
7.11.2 Merck KGaA Business Overview
7.11.3 Merck KGaA Precision Cancer Medicine Major Product Offerings
7.11.4 Merck KGaA Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.11.5 Merck KGaA Key News＆Latest Developments
7.12 Seagen
7.12.1 Seagen Company Summary
7.12.2 Seagen Business Overview
7.12.3 Seagen Precision Cancer Medicine Major Product Offerings
7.12.4 Seagen Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.12.5 Seagen Key News＆Latest Developments
7.13 Eli Lilly
7.13.1 Eli Lilly Company Summary
7.13.2 Eli Lilly Business Overview
7.13.3 Eli Lilly Precision Cancer Medicine Major Product Offerings
7.13.4 Eli Lilly Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.13.5 Eli Lilly Key News＆Latest Developments
7.14 Ono Pharmaceutical
7.14.1 Ono Pharmaceutical Company Summary
7.14.2 Ono Pharmaceutical Business Overview
7.14.3 Ono Pharmaceutical Precision Cancer Medicine Major Product Offerings
7.14.4 Ono Pharmaceutical Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.14.5 Ono Pharmaceutical Key News＆Latest Developments
7.15 Pfizer
7.15.1 Pfizer Company Summary
7.15.2 Pfizer Business Overview
7.15.3 Pfizer Precision Cancer Medicine Major Product Offerings
7.15.4 Pfizer Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.15.5 Pfizer Key News＆Latest Developments
7.16 GSK
7.16.1 GSK Company Summary
7.16.2 GSK Business Overview
7.16.3 GSK Precision Cancer Medicine Major Product Offerings
7.16.4 GSK Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.16.5 GSK Key News＆Latest Developments
7.17 Exelixis
7.17.1 Exelixis Company Summary
7.17.2 Exelixis Business Overview
7.17.3 Exelixis Precision Cancer Medicine Major Product Offerings
7.17.4 Exelixis Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.17.5 Exelixis Key News＆Latest Developments
7.18 Regeneron
7.18.1 Regeneron Company Summary
7.18.2 Regeneron Business Overview
7.18.3 Regeneron Precision Cancer Medicine Major Product Offerings
7.18.4 Regeneron Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.18.5 Regeneron Key News＆Latest Developments
7.19 Innovent
7.19.1 Innovent Company Summary
7.19.2 Innovent Business Overview
7.19.3 Innovent Precision Cancer Medicine Major Product Offerings
7.19.4 Innovent Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.19.5 Innovent Key News＆Latest Developments
7.20 Hengrui Medicine
7.20.1 Hengrui Medicine Company Summary
7.20.2 Hengrui Medicine Business Overview
7.20.3 Hengrui Medicine Precision Cancer Medicine Major Product Offerings
7.20.4 Hengrui Medicine Precision Cancer Medicine Revenue in Global Market (2018-2023)
7.20.5 Hengrui Medicine Key News＆Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Precision Cancer Medicine Market Opportunities＆Trends in Global Market
Table 2. Precision Cancer Medicine Market Drivers in Global Market
Table 3. Precision Cancer Medicine Market Restraints in Global Market
Table 4. Key Players of Precision Cancer Medicine in Global Market
Table 5. Top Precision Cancer Medicine Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Precision Cancer Medicine Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Precision Cancer Medicine Revenue Share by Companies, 2018-2023
Table 8. Global Companies Precision Cancer Medicine Product Type
Table 9. List of Global Tier 1 Precision Cancer Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Precision Cancer Medicine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Precision Cancer Medicine Revenue, (US$, Mn), 2022＆2029
Table 12. By Type - Precision Cancer Medicine Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Precision Cancer Medicine Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Precision Cancer Medicine Revenue, (US$, Mn), 2022＆2029
Table 15. By Application - Precision Cancer Medicine Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Precision Cancer Medicine Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Precision Cancer Medicine Revenue, (US$, Mn), 2022＆2029
Table 18. By Region - Global Precision Cancer Medicine Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Precision Cancer Medicine Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Precision Cancer Medicine Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Precision Cancer Medicine Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Precision Cancer Medicine Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Precision Cancer Medicine Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Precision Cancer Medicine Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Precision Cancer Medicine Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Precision Cancer Medicine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Precision Cancer Medicine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East＆Africa Precision Cancer Medicine Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East＆Africa Precision Cancer Medicine Revenue, (US$, Mn), 2024-2029
Table 30. AbbVie Company Summary
Table 31. AbbVie Precision Cancer Medicine Product Offerings
Table 32. AbbVie Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 33. AbbVie Key News＆Latest Developments
Table 34. Johnson＆Johnson Company Summary
Table 35. Johnson＆Johnson Precision Cancer Medicine Product Offerings
Table 36. Johnson＆Johnson Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 37. Johnson＆Johnson Key News＆Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Precision Cancer Medicine Product Offerings
Table 40. Novartis Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 41. Novartis Key News＆Latest Developments
Table 42. Gilead Sciences Company Summary
Table 43. Gilead Sciences Precision Cancer Medicine Product Offerings
Table 44. Gilead Sciences Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 45. Gilead Sciences Key News＆Latest Developments
Table 46. Roche Company Summary
Table 47. Roche Precision Cancer Medicine Product Offerings
Table 48. Roche Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 49. Roche Key News＆Latest Developments
Table 50. Bristol-Myers Squibb Company Summary
Table 51. Bristol-Myers Squibb Precision Cancer Medicine Product Offerings
Table 52. Bristol-Myers Squibb Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 53. Bristol-Myers Squibb Key News＆Latest Developments
Table 54. Amgen Company Summary
Table 55. Amgen Precision Cancer Medicine Product Offerings
Table 56. Amgen Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 57. Amgen Key News＆Latest Developments
Table 58. AstraZeneca Company Summary
Table 59. AstraZeneca Precision Cancer Medicine Product Offerings
Table 60. AstraZeneca Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 61. AstraZeneca Key News＆Latest Developments
Table 62. Merck＆Co Company Summary
Table 63. Merck＆Co Precision Cancer Medicine Product Offerings
Table 64. Merck＆Co Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 65. Merck＆Co Key News＆Latest Developments
Table 66. Takeda Company Summary
Table 67. Takeda Precision Cancer Medicine Product Offerings
Table 68. Takeda Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 69. Takeda Key News＆Latest Developments
Table 70. Merck KGaA Company Summary
Table 71. Merck KGaA Precision Cancer Medicine Product Offerings
Table 72. Merck KGaA Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 73. Merck KGaA Key News＆Latest Developments
Table 74. Seagen Company Summary
Table 75. Seagen Precision Cancer Medicine Product Offerings
Table 76. Seagen Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 77. Seagen Key News＆Latest Developments
Table 78. Eli Lilly Company Summary
Table 79. Eli Lilly Precision Cancer Medicine Product Offerings
Table 80. Eli Lilly Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 81. Eli Lilly Key News＆Latest Developments
Table 82. Ono Pharmaceutical Company Summary
Table 83. Ono Pharmaceutical Precision Cancer Medicine Product Offerings
Table 84. Ono Pharmaceutical Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 85. Ono Pharmaceutical Key News＆Latest Developments
Table 86. Pfizer Company Summary
Table 87. Pfizer Precision Cancer Medicine Product Offerings
Table 88. Pfizer Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 89. Pfizer Key News＆Latest Developments
Table 90. GSK Company Summary
Table 91. GSK Precision Cancer Medicine Product Offerings
Table 92. GSK Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 93. GSK Key News＆Latest Developments
Table 94. Exelixis Company Summary
Table 95. Exelixis Precision Cancer Medicine Product Offerings
Table 96. Exelixis Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 97. Exelixis Key News＆Latest Developments
Table 98. Regeneron Company Summary
Table 99. Regeneron Precision Cancer Medicine Product Offerings
Table 100. Regeneron Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 101. Regeneron Key News＆Latest Developments
Table 102. Innovent Company Summary
Table 103. Innovent Precision Cancer Medicine Product Offerings
Table 104. Innovent Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 105. Innovent Key News＆Latest Developments
Table 106. Hengrui Medicine Company Summary
Table 107. Hengrui Medicine Precision Cancer Medicine Product Offerings
Table 108. Hengrui Medicine Precision Cancer Medicine Revenue (US$, Mn)＆(2018-2023)
Table 109. Hengrui Medicine Key News＆Latest Developments
List of Figures
Figure 1. Precision Cancer Medicine Segment by Type in 2022
Figure 2. Precision Cancer Medicine Segment by Application in 2022
Figure 3. Global Precision Cancer Medicine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Precision Cancer Medicine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Precision Cancer Medicine Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Precision Cancer Medicine Revenue in 2022
Figure 8. By Type - Global Precision Cancer Medicine Revenue Market Share, 2018-2029
Figure 9. By Application - Global Precision Cancer Medicine Revenue Market Share, 2018-2029
Figure 10. By Type - Global Precision Cancer Medicine Revenue, (US$, Mn), 2022＆2029
Figure 11. By Type - Global Precision Cancer Medicine Revenue Market Share, 2018-2029
Figure 12. By Application - Global Precision Cancer Medicine Revenue, (US$, Mn), 2022＆2029
Figure 13. By Application - Global Precision Cancer Medicine Revenue Market Share, 2018-2029
Figure 14. By Region - Global Precision Cancer Medicine Revenue Market Share, 2018-2029
Figure 15. By Country - North America Precision Cancer Medicine Revenue Market Share, 2018-2029
Figure 16. US Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Precision Cancer Medicine Revenue Market Share, 2018-2029
Figure 20. Germany Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 21. France Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Precision Cancer Medicine Revenue Market Share, 2018-2029
Figure 28. China Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 32. India Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Precision Cancer Medicine Revenue Market Share, 2018-2029
Figure 34. Brazil Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East＆Africa Precision Cancer Medicine Revenue Market Share, 2018-2029
Figure 37. Turkey Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Precision Cancer Medicine Revenue, (US$, Mn), 2018-2029
Figure 41. AbbVie Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 42. Johnson＆Johnson Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 43. Novartis Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 44. Gilead Sciences Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 45. Roche Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 46. Bristol-Myers Squibb Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 47. Amgen Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 48. AstraZeneca Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 49. Merck＆Co Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 50. Takeda Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 51. Merck KGaA Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 52. Seagen Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 53. Eli Lilly Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 54. Ono Pharmaceutical Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 55. Pfizer Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 56. GSK Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 57. Exelixis Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 58. Regeneron Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 59. Innovent Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)
Figure 60. Hengrui Medicine Precision Cancer Medicine Revenue Year Over Year Growth (US$, Mn)＆(2018-2023)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 血液腫瘍薬のグローバル市場展望 2023年-2029年：化学療法、標的療法、免疫療法、その他
  • ホルモン放出アゴニストのグローバル市場展望 2023年-2029年：ホルモン療法、免疫療法、標的療法、化学療法、その他
  • 血液腫瘍薬の世界市場2023年：化学療法、標的療法、免疫療法、その他
  • がん治療&検査装置のグローバル市場展望 2023年-2029年：がん検出、がん治療
  • 標的癌治療のグローバル市場展望 2023年-2029年：キナーゼ阻害剤、モノクローナル抗体、PARP阻害剤、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14526 )"精密がん医療のグローバル市場展望 2023年-2029年：がん免疫療法、標的療法" (英文：Precision Cancer Medicine Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。